GR861425B - Tetrahydroimidazoquinazolinone cardiac stimulants - Google Patents

Tetrahydroimidazoquinazolinone cardiac stimulants

Info

Publication number
GR861425B
GR861425B GR861425A GR860101425A GR861425B GR 861425 B GR861425 B GR 861425B GR 861425 A GR861425 A GR 861425A GR 860101425 A GR860101425 A GR 860101425A GR 861425 B GR861425 B GR 861425B
Authority
GR
Greece
Prior art keywords
tetrahydroimidazoquinazolinone
cardiac stimulants
stimulants
cardiac
tetrahydroimidazoquinazolinone cardiac
Prior art date
Application number
GR861425A
Other languages
English (en)
Inventor
Fraser Simon Dr Campbell
Roberts David Dr Anthony
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858514207A external-priority patent/GB8514207D0/en
Priority claimed from GB858527208A external-priority patent/GB8527208D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of GR861425B publication Critical patent/GR861425B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR861425A 1985-06-05 1986-06-02 Tetrahydroimidazoquinazolinone cardiac stimulants GR861425B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858514207A GB8514207D0 (en) 1985-06-05 1985-06-05 Cardiac stimulants
GB858527208A GB8527208D0 (en) 1985-11-05 1985-11-05 Cardiac stimulants

Publications (1)

Publication Number Publication Date
GR861425B true GR861425B (en) 1986-10-02

Family

ID=26289332

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861425A GR861425B (en) 1985-06-05 1986-06-02 Tetrahydroimidazoquinazolinone cardiac stimulants

Country Status (16)

Country Link
US (1) US4783467A (el)
EP (1) EP0205280A3 (el)
KR (1) KR870001362B1 (el)
CN (1) CN86103833A (el)
AU (1) AU562773B2 (el)
CA (1) CA1270486A (el)
DK (1) DK262486A (el)
ES (2) ES8708139A1 (el)
FI (1) FI862375A (el)
GR (1) GR861425B (el)
HU (1) HU196408B (el)
IL (1) IL79003A0 (el)
NO (1) NO862233L (el)
NZ (1) NZ216386A (el)
PT (1) PT82702B (el)
YU (1) YU95186A (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8383637B2 (en) * 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8426429B2 (en) * 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
CN117062819A (zh) * 2021-03-23 2023-11-14 北京生命科学研究所 多环化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
EP0054180A3 (de) * 1980-12-16 1982-12-01 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung eines Imidazochinazolinonderivates
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
US4593029A (en) * 1984-02-15 1986-06-03 Syntex (U.S.A.) Inc. Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents

Also Published As

Publication number Publication date
EP0205280A3 (en) 1988-11-30
FI862375A (fi) 1986-12-06
AU562773B2 (en) 1987-06-18
ES555723A0 (es) 1987-09-16
FI862375A0 (fi) 1986-06-04
KR870000338A (ko) 1987-02-17
PT82702B (pt) 1988-12-15
NZ216386A (en) 1988-08-30
US4783467A (en) 1988-11-08
DK262486A (da) 1987-02-16
YU95186A (en) 1988-04-30
CN86103833A (zh) 1986-12-31
HUT41793A (en) 1987-05-28
ES8800224A1 (es) 1987-10-16
IL79003A0 (en) 1986-09-30
HU196408B (en) 1988-11-28
ES557427A0 (es) 1987-10-16
EP0205280A2 (en) 1986-12-17
ES8708139A1 (es) 1987-09-16
KR870001362B1 (ko) 1987-07-20
NO862233D0 (no) 1986-06-04
NO862233L (no) 1986-12-08
DK262486D0 (da) 1986-06-04
AU5842786A (en) 1986-12-11
PT82702A (en) 1986-07-01
CA1270486A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
GB8529067D0 (en) Diagnosis
GB8613460D0 (en) Dishwasher
EP0215730A3 (en) Heart stimulator
EP0215729A3 (en) Heart stimulator
EP0226164A3 (en) Cardiac pace-maker
EP0215731A3 (en) Heart stimulator
EP0216725A3 (en) Heart stimulator
CS119486A2 (en) Obrazovka s vnitrnim magnetickym stinenim
GB8529362D0 (en) Quinolone cardiac stimulants
GB8320958D0 (en) Quinazoline cardiac stimulants
GR861425B (en) Tetrahydroimidazoquinazolinone cardiac stimulants
DE3665012D1 (en) Double-hose stethoscope
GB8514207D0 (en) Cardiac stimulants
GB2180441B (en) Dishwasher
ZA833422B (en) Cardiac stimulants
GB8619902D0 (en) Quinolone cardiac stimulants
YU131988A (en) Heart
GB8527208D0 (en) Cardiac stimulants
IE842885L (en) Cardiac stimulants
IE861462L (en) Tetrahydroimidazoquinazolinone cardiac stimulants
CS649585A1 (en) Tvarniaci nastroj s telesami z nezeleznej zliatiny
AU97452S (en) Dishwasher
IE863125L (en) Quinolone cardiac stimulants
GB8523514D0 (en) Cardiac monitoring
GB8509150D0 (en) Cardiac monitoring